[CR1] Cella D, Peterman A, Passik S, Jacobsen P, Breitbart W. Progress toward guidelines for the management of fatigue. Oncol (Williston Park). 1998;12(11A):369–77. 10028520

[CR2] Berger AM, Mooney K, Alvarez-Perez A, Breitbart WS, Carpenter KM, Cella D, et al. Cancer-Related fatigue, version 2.2015. J Natl Compr Canc Netw. 2015;13(8):1012–39. 10.6004/jnccn.2015.0122. 26285247 10.6004/jnccn.2015.0122 PMC5499710

[CR3] Servaes P, Verhagen S, Bleijenberg G. Determinants of chronic fatigue in disease-free breast cancer patients: a cross-sectional study. Ann Oncol. 2002;13(4):589–98. 10.1093/annonc/mdf082. 12056710 10.1093/annonc/mdf082

[CR4] Wang XS, Zhao F, Fisch MJ, O’Mara AM, Cella D, Mendoza TR, et al. Prevalence and characteristics of moderate to severe fatigue: a multicenter study in cancer patients and survivors. Cancer. 2014;120(3):425–32. 10.1002/cncr.28434. 24436136 10.1002/cncr.28434 PMC3949157

[CR5] Abrahams HJG, Gielissen MFM, Verhagen C, Knoop H. The relationship of fatigue in breast cancer survivors with quality of life and factors to address in psychological interventions: A systematic review. Clin Psychol Rev. 2018;63:1–11. 10.1016/j.cpr.2018.05.004. 29852324 10.1016/j.cpr.2018.05.004

[CR6] Abrahams HJG, Gielissen MFM, Schmits IC, Verhagen CAHHVM, Knoop H. Risk factors, prevalence, and course of severe fatigue after breast cancer treatment: A meta-analysis involving 12,327 breast cancer survivors. Ann Oncol. 2016;27(6):965–74. 10.1093/annonc/mdw099. 26940687 10.1093/annonc/mdw099

[CR7] Schmidt ME, Chang-Claude J, Seibold P, Vrieling A, Heinz J, Flesch-Janys D, et al. Determinants of long-term fatigue in breast cancer survivors: results of a prospective patient cohort study. Psychooncology. 2015;24(1):40–6. 10.1002/pon.3581. 24839264 10.1002/pon.3581

[CR8] Collado-Hidalgo A, Bower JE, Ganz PA, Cole SW, Irwin MR. Inflammatory biomarkers for persistent fatigue in breast cancer survivors. Clin Cancer Res. 2006;12(9):2759–66. 10.1158/1078-0432.CCR-05-2398. 16675568 10.1158/1078-0432.CCR-05-2398

[CR9] Cohen RA, Gullett JM, Woods AJ, Porges EC, Starkweather A, Jackson-Cook CK, et al. Cytokine-associated fatigue prior to, during, and post-chemotherapy for breast cancer. J Neuroimmunol. 2019;334:577001. 10.1016/j.jneuroim.2019.577001. 31260949 10.1016/j.jneuroim.2019.577001 PMC7363023

[CR10] Illi J Miaskowski C Cooper B Levine JD Dunn L West C Association between pro-inflammatory cytokine genes and symptom clusters in patients undergoing radiation therapy Cytokine 2012 58 2 403 10

[CR11] Nance DM, Sanders VM. Autonomic innervation and regulation of the immune system (1987–2007). Brain Behav Immun. 2007;21(6):736–45. 10.1016/j.bbi.2007.03.008. 17467231 10.1016/j.bbi.2007.03.008 PMC1986730

[CR12] Bower JE, Ganz PA, Aziz N. Altered cortisol response to psychologic stress in breast cancer survivors with persistent fatigue. Psychosom Med. 2005;67(2):277–80. 10.1097/01.psy.0000155666.55034.c6. 15784794 10.1097/01.psy.0000155666.55034.c6

[CR13] Bower JE. Cancer-related fatigue–mechanisms, risk factors, and treatments. Nat Rev Clin Oncol. 2014;11(10):597–609. 10.1038/nrclinonc.2014.127. 25113839 10.1038/nrclinonc.2014.127 PMC4664449

[CR14] Lawrence DP, Kupelnick B, Miller K, Devine D, Lau J. Evidence report on the occurrence, assessment, and treatment of fatigue in cancer patients. J Natl Cancer Inst Monogr. 2004;32(32):40–50. 10.1093/jncimonographs/lgh027. 10.1093/jncimonographs/lgh027 15263040

[CR15] Garcia-Gonzalez D, Romero-Elias M, Alvarez-Bustos A, Rosado-Garcia S, Sanchez-Lopez AJ, Cantos B, et al. Cancer-Related fatigue and Circulating biomarkers in breast Cancer survivors. Biol Res Nurs. 2024;26(2):270–8. 10.1177/10998004231215777. 37947791 10.1177/10998004231215777

[CR16] Argiles JM, Busquets S, Stemmler B, Lopez-Soriano FJ. Cancer cachexia: Understanding the molecular basis. Nat Rev Cancer. 2014;14(11):754–62. 10.1038/nrc3829. 25291291 10.1038/nrc3829

[CR17] Gilliam LA, St Clair DK. Chemotherapy-induced weakness and fatigue in skeletal muscle: the role of oxidative stress. Antioxid Redox Signal. 2011;15(9):2543–63. 10.1089/ars.2011.3965. 21457105 10.1089/ars.2011.3965 PMC3176345

[CR18] Fagundes CP, Murray DM, Hwang BS, Gouin JP, Thayer JF, Sollers JJ 3, et al. Sympathetic and parasympathetic activity in cancer-related fatigue: more evidence for a physiological substrate in cancer survivors. Psychoneuroendocrinology. 2011;36(8):1137–47. 10.1016/j.psyneuen.2011.02.005. 10.1016/j.psyneuen.2011.02.005 PMC3128662 21388744

[CR19] Bean HR, Diggens J, Ftanou M, Weihs KL, Stanton AL, Wiley JF. Insomnia and fatigue symptom trajectories in breast cancer: A longitudinal cohort study. Behav Sleep Med. 2021;19(6):814–27. 10.1080/15402002.2020.1869005. 33470847 10.1080/15402002.2020.1869005

[CR20] Savard J, Morin CM. Insomnia in the context of cancer: a review of a neglected problem. J Clin Oncol. 2001;19(3):895–908. 10.1200/JCO.2001.19.3.895. 11157043 10.1200/JCO.2001.19.3.895

[CR21] Fiorentino L, Rissling M, Liu L, Ancoli-Israel S. The symptom cluster of sleep, fatigue and depressive symptoms in breast Cancer patients: severity of the problem and treatment options. Drug Discov Today Dis Models. 2011;8(4):167–73. 10.1016/j.ddmod.2011.05.001. 22140397 10.1016/j.ddmod.2011.05.001 PMC3228259

[CR22] Broeckel JA, Jacobsen PB, Horton J, Balducci L, Lyman GH. Characteristics and correlates of fatigue after adjuvant chemotherapy for breast cancer. J Clin Oncol. 1998;16(5):1689–96. 10.1200/JCO.1998.16.5.1689. 9586880 10.1200/JCO.1998.16.5.1689

[CR23] Mustian KM, Alfano CM, Heckler C, Kleckner AS, Kleckner IR, Leach CR, et al. Comparison of pharmaceutical, psychological, and exercise treatments for Cancer-Related fatigue: A Meta-analysis. JAMA Oncol. 2017;3(7):961–8. 10.1001/jamaoncol.2016.6914. 28253393 10.1001/jamaoncol.2016.6914 PMC5557289

[CR24] Feng LR, Regan J, Shrader JA, Liwang J, Ross A, Kumar S, et al. Cognitive and motor aspects of cancer-related fatigue. Cancer Med. 2019;8(13):5840–9. 10.1002/cam4.2490. 31407525 10.1002/cam4.2490 PMC6792503

[CR25] Pomykala KL, Ganz PA, Bower JE, Kwan L, Castellon SA, Irwin MR. The association between pro-inflammatory cytokines, regional cerebral metabolism, and fatigue in breast cancer. Brain Imaging Behav. 2013;7(4):511–23. 23835929 10.1007/s11682-013-9243-2 PMC4399818

[CR26] Capuron L Welberg L Heim C Cognitive dysfunction relates to excessive psychomotor slowing and Proinflammatory cytokine release in cancer patients treated with cytokines Mol Psychiatry 2008 6 1 68 75

[CR27] Landmark-Hoyvik H, Reinertsen KV, Loge JH, Fossa SD, Borresen-Dale AL, Dumeaux V. Alterations of gene expression in blood cells associated with chronic fatigue in breast cancer survivors. Pharmacogenomics J. 2009;9(5):333–40. 10.1038/tpj.2009.27. 19546881 10.1038/tpj.2009.27

[CR28] Palesh O, Peppone L, Innominato P. Prevalence, putative mechanisms, and current management of sleep problems during chemotherapy for cancer. Nat Sci Sleep. 2013;5:151–5. 10.2147/NSS.S18895 PMC3593248 23486503

[CR29] Prue G, Rankin J, Allen J, Gracey J, Cramp F. Cancer-related fatigue: A critical appraisal. Eur J Cancer. 2006;42(7):846–63. 10.1016/j.ejca.2005.11.026. 16460928 10.1016/j.ejca.2005.11.026

[CR30] Crosswell AD, Lockwood KG. Best practices for stress measurement: how to measure psychological stress in health research. Health Psychol Open. 2020;7(2):2055102920933072. 32704379 10.1177/2055102920933072 PMC7359652

[CR31] Schmitz K. Physical activity and breast cancer survivorship. Recent Results Cancer Res. 2011;186:189–215. 10.1007/978-3-642-04231-7_8. 21113765 10.1007/978-3-642-04231-7_8

[CR32] Buffart LM, Sweegers MG, May AM, Chinapaw MJ, van Vulpen JK, Newton RU, et al. Targeting exercise interventions to patients with Cancer in need: an individual patient data Meta-Analysis. J Natl Cancer Inst. 2018;110(11):1190–200. 10.1093/jnci/djy161. 30299508 10.1093/jnci/djy161 PMC6454466

[CR33] Fabi A, Bhargava R, Fatigoni S, Guglielmo M, Horneber M, Roila F, et al. Cancer-related fatigue: ESMO clinical practice guidelines for diagnosis and treatment. Ann Oncol. 2020;31(6):713–23. 10.1016/j.annonc.2020.02.016. 32173483 10.1016/j.annonc.2020.02.016

[CR34] Stone P, Hardy J, Broadley K, Tookman AJ, Kurowska A, A’Hern R. Fatigue in advanced cancer: a prospective controlled cross-sectional study. Br J Cancer. 1999;79(9–10):1479–86. 10.1038/sj.bjc.6690236. 10188894 10.1038/sj.bjc.6690236 PMC2362706

[CR35] Bower JE, Bak K, Berger A, Breitbart W, Escalante CP, Ganz PA, et al. Screening, assessment, and management of fatigue in adult survivors of cancer: an American society of clinical oncology clinical practice guideline adaptation. J Clin Oncol. 2014;32(17):1840–50. 10.1200/JCO.2013.53.4495. 24733803 10.1200/JCO.2013.53.4495 PMC4039870

[CR36] Gradishar WJ, Anderson BO, Abraham J, Aft R, Agnese D, Allison KH, et al. Breast cancer, version 3.2020, NCCN clinical practice guidelines in oncology. J Natl Compr Canc Netw. 2020;18(4):452–78. 10.6004/jnccn.2020.0016. 32259783 10.6004/jnccn.2020.0016

[CR37] Smets EM, Garssen B, Bonke B, De Haes JC. The multidimensional fatigue inventory (MFI): psychometric qualities of an instrument to assess fatigue. J Psychosom Res. 1998;39(3):315–25. 10.1016/0022-3999(94)00125-o 7636775

[CR38] Weis J, Wirtz MA, Tomaszewski KA, Hammerlid E, Arraras JI, Conroy T, et al. Sensitivity to change of the EORTC quality of life module measuring cancer-related fatigue (EORTC QlQ-Fa12): results from the international psychometric validation. Psychooncology. 2019;28(8):1753–61. 10.1002/pon.5151. 31225669 10.1002/pon.5151

[CR39] De Nardi L, Lanzetta MA, Ghirigato E, Barbi E, Gortani G. Approach to the child with fatigue: A focus for the general pediatrician. Front Pediatr. 2022;10:1044170. 10.3389/fped.2022.1044170. 36533226 10.3389/fped.2022.1044170 PMC9755349

[CR40] Gerber LH, Stout N, McGarvey C. Factors predicting clinically significant fatigue in women following treatment for primary breast cancer. Support Care Cancer. 2017;25(3):919–27. 10.1007/s00520-010-0986-7 PMC3166607 20835835

[CR41] Hofman M, Ryan JL, Figueroa-Moseley CD, Jean-Pierre P, Morrow GR. Cancer-related fatigue: the scale of the problem. Oncologist. 2007;12(Suppl 1):4–10. 10.1634/theoncologist.12-S1-4. 17573451 10.1634/theoncologist.12-S1-4

[CR42] Stone P, Richards M, Hardy J. Fatigue in patients with breast and prostate cancer undergoing radical radiotherapy. J Pain Symptom Manag. 2001;22(5):1007–11. 10.1016/s0885-3924(01)00361-x 11738163

[CR43] Schwartz AL, Mori M, Gao R, Nail LM, King ME. Exercise reduces daily fatigue in women with breast cancer receiving chemotherapy. Med Sci Sports Exerc. 2001;33(5):718–23. 10.1097/00005768-200105000-00006. 11323538 10.1097/00005768-200105000-00006

[CR44] Egelston CA, Guo W, Yost SE, Ge X, Lee JS, Frankel PH, et al. Immunogenicity and efficacy of pembrolizumab and doxorubicin in a phase I trial for patients with metastatic triple-negative breast cancer. Cancer Immunol Immunother. 2023;72(9):3013–27. 10.1007/s00262-023-03470-y. 37294342 10.1007/s00262-023-03470-y PMC10412661

[CR45] Wan BA, Pidduck W, Zhang L, Nolen A, Drost L, Yee C, et al. Patient-reported fatigue in breast cancer patients receiving radiation therapy. Breast. 2019;47:10–5. 10.1016/j.breast.2019.06.004. 31255946 10.1016/j.breast.2019.06.004

[CR46] Greenlee H, DuPont-Reyes MJ, Balneaves LG, Carlson LE, Cohen MR, Deng G, et al. Clinical practice guidelines on the evidence-based use of integrative therapies during and after breast cancer treatment. CA Cancer J Clin. 2017;67(3):194–232. 10.3322/caac.21397. 28436999 10.3322/caac.21397 PMC5892208

[CR47] Nakata B, Sakimura C, Tendo M, Tsukida T, Hori T, Hirakawa K, et al. Palliative care for patients with breast Cancer in a palliative care unit of a Japanese hospital. Cureus. 2024;16(8):e67834. 10.7759/cureus.67834. 39323704 10.7759/cureus.67834 PMC11424012

[CR48] Miller KD, Nogueira L, Devasia T, Mariotto AB, Yabroff KR, Jemal A, et al. Cancer treatment and survivorship statistics, 2022. CA Cancer J Clin. 2022;72(5):409–36. 10.3322/caac.21731. 35736631 10.3322/caac.21731

[CR49] Runowicz CD, Leach CR, Henry NL, Henry KS, Mackey HT, Cowens-Alvarado RL, et al. American Cancer society/american society of clinical oncology breast Cancer survivorship care guideline. J Clin Oncol. 2016;34(6):611–35. 10.1200/JCO.2015.64.3809. 26644543 10.1200/JCO.2015.64.3809

[CR50] Mustian KM Alfano CM Heckler CE Comparison of pharmacological, psychological, and exercise treatments for cancer-related fatigue: an update of a 2017 systematic review and meta-analysis J Natl Compr Canc Netw 2020 18 8 1046 53

[CR51] Cramer H, Lange S, Klose P, Paul A, Dobos G. Yoga for breast cancer patients and survivors: A systematic review and meta-analysis. BMC Cancer. 2015;15(1):294. 10.1186/s12885-015-1291-7. 22988934 10.1186/1471-2407-12-412 PMC3527138

[CR52] Tomlinson D, Robinson PD, Oberoi S, Cataudella D, Culos-Reed N, Davis H, et al. Pharmacologic interventions for fatigue in cancer and transplantation: a meta-analysis. Curr Oncol. 2018;25(2):e152–67. 10.3747/co.25.3883. 29719440 10.3747/co.25.3883 PMC5927795

[CR53] Jones JM, Olson K, Catton P, Catton CN, Fleshner NE, Krzyzanowska MK, et al. Cancer-related fatigue and associated disability in post-treatment cancer survivors. J Cancer Surviv. 2016;10(1):51–61. 10.1007/s11764-015-0450-2. 25876557 10.1007/s11764-015-0450-2

[CR54] Almerud A, Frisk G, Klasson C, Bjorkhem-Bergman L. Methylphenidate for treating fatigue in palliative cancer care - effect and side effects in real-world data from a palliative care unit. Acta Oncol. 2024;63:9–16. 10.2340/1651-226X.2024.24156. 38348853 10.2340/1651-226X.2024.24156 PMC11332525

[CR55] Bruera E, Valero V, Driver L, Shen L, Willey J, Zhang T, et al. Patient-controlled methylphenidate for cancer fatigue: a double-blind, randomized, placebo-controlled trial. J Clin Oncol. 2006;24(13):2073–8. 10.1200/JCO.2005.02.8506. 16648508 10.1200/JCO.2005.02.8506

[CR56] Loprinzi CL, Kugler JW, Sloan JA, Phase III. randomized, double-blind, placebo-controlled study of methylphenidate for patients with cancer-related fatigue: North central Cancer treatment group N05C7. J Clin Oncol. 2010;28(23):3673–9. 10.1200/JCO.2010.28.1444 PMC2917307 20625123

[CR57] Spathis A, Dhillan R, Booden D, Forbes K, Vrotsou K, Fife K. Modafinil for the treatment of fatigue in lung cancer: a pilot study. Palliat Med. 2009;23(4):325–31. 10.1177/0269216309102614. 19270033 10.1177/0269216309102614

[CR58] Jean-Pierre P, Morrow GR, Roscoe JA, Heckler C, Mohile S, Janelsins M, et al. A phase 3 randomized, placebo-controlled, double-blind, clinical trial of the effect of modafinil on cancer-related fatigue among 631 patients receiving chemotherapy: a university of Rochester Cancer center community clinical oncology program research base study. Cancer. 2010;116(14):3513–20. 10.1002/cncr.25083. 20564068 10.1002/cncr.25083 PMC2941794

[CR59] Spathis A, Fife K, Blackhall F, Dutton S, Bahadori R, Wharton R, et al. Modafinil for the treatment of fatigue in lung cancer: results of a placebo-controlled, double-blind, randomized trial. J Clin Oncol. 2014;32(18):1882–8. 10.1200/JCO.2013.54.4346. 24778393 10.1200/JCO.2013.54.4346

[CR60] Pituskin E, Haykowsky M, McNeely M, Mackey J, Chua N, Paterson I. Rationale and design of the multidisciplinary team intervention in cArdio-oNcology study (TITAN). BMC Cancer. 2016;16(1):733. 10.1186/s12885-016-2761-8. 27629548 10.1186/s12885-016-2761-8 PMC5024526

[CR61] Sun X, Chen Y, Cheung WKW, Wu IXY, Xiao F, Chung VCH. Pharmacological interventions for the management of cancer-related fatigue among cancer survivors: systematic review and meta-analysis. Integr Cancer Ther. 2021;20:15347354211038008. 34369188 10.1177/15347354211038008 PMC8358505

[CR62] Minton O, Stone P. How common is fatigue in disease-free breast cancer survivors? A systematic review of the literature. Breast Cancer Res Treat. 2008;112(1):5–13. 18064565 10.1007/s10549-007-9831-1

[CR63] Stone PC. Methylphenidate in the management of cancer-related fatigue. J Clin Oncol. 2013;31(19):2372–3. 10.1200/JCO.2013.50.0181. 23690419 10.1200/JCO.2013.50.0181

[CR64] Bower JE, Lacchetti C, Alici Y, Barton DL, Bruner D, Canin BE, et al. Management of fatigue in adult survivors of cancer: ASCO-Society for integrative oncology guideline update. J Clin Oncol. 2024;42(20):2456–87. 10.1200/JCO.24.00541. 38754041 10.1200/JCO.24.00541 PMC12082589

[CR65] Thong MSY, van Noorden CJF, Steindorf K, Arndt V. Cancer-Related fatigue: causes and current treatment options. Curr Treat Options Oncol. 2020;21(2):17. 10.1007/s11864-020-0707-5. 32025928 10.1007/s11864-020-0707-5 PMC8660748

[CR66] Edwards JG, Anderson I. Systematic review and guide to selection of selective serotonin reuptake inhibitors. Drugs. 1999;57(4):507–33. 10.2165/00003495-199957040-00005. 10235690 10.2165/00003495-199957040-00005

[CR67] Cullum JL, Wojciechowski AE, Pelletier G, Simpson JS. Bupropion sustained release treatment reduces fatigue in cancer patients. Can J Psychiatry. 2004;49(2):139–44. 10.1177/070674370404900209. 15065748 10.1177/070674370404900209

[CR68] Salehifar E, Azimi S, Janbabai G, Zaboli E, Hendouei N, Saghafi F, et al. Efficacy and safety of bupropion in cancer-related fatigue, a randomized double blind placebo controlled clinical trial. BMC Cancer. 2020;20(1):158. 10.1186/s12885-020-6618-9. 32106832 10.1186/s12885-020-6618-9 PMC7045731

[CR69] Ashrafi F, Mousavi S, Karimi M. Potential role of bupropion sustained release for Cancer-Related fatigue: a Double-Blind, Placebo-Controlled study. Asian Pac J Cancer Prev. 2018;19(6):1547–51. 10.22034/APJCP.2018.19.6.1547. 29936730 10.22034/APJCP.2018.19.6.1547 PMC6103561

[CR70] Haque R, Shi J, Schottinger JE, Ahmed SA, Cheetham TC, Chung J, et al. Tamoxifen and antidepressant drug interaction in a cohort of 16,887 breast Cancer survivors. J Natl Cancer Inst. 2016;108(3). 10.1093/jnci/djv337. 10.1093/jnci/djv337 PMC5072369 26631176

[CR71] Jim HSL, Hoogland AI, Han HS, Culakova E, Heckler C, Janelsins M, et al. A randomized placebo-controlled trial of bupropion for Cancer-related fatigue: study design and procedures. Contemp Clin Trials. 2020;91:105976. 10.1016/j.cct.2020.105976. 32147571 10.1016/j.cct.2020.105976 PMC7263969

[CR72] Kronenberg F Shani A Ginsberg G Efficacy of amantadine in managing cancer-related fatigue: A systematic review and meta-analysis Oncologist 2015 20 8 876 85 10.1634/theoncologist.2015-0037

[CR73] Miladinia M, Jahangiri M, White SJ, Karimpourian H, Inno A, Chan SW, et al. 5-EPIFAT trial protocol: a multi-center, randomized, placebo-controlled trial of the efficacy of pharmacotherapy for fatigue using methylphenidate, bupropion, ginseng, and amantadine in advanced cancer patients on active treatment. Trials. 2024;25(1):230. 10.1186/s13063-024-08078-w. 38570861 10.1186/s13063-024-08078-w PMC10988831

[CR74] Chow R, Novosel M, So OW, Bellampalli S, Xiang J, Boldt G, et al. Duloxetine for prevention and treatment of chemotherapy-induced peripheral neuropathy (CIPN): systematic review and meta-analysis. BMJ Support Palliat Care. 2023;13(1):27–34. 10.1136/spcare-2022-003815. 36194493 10.1136/spcare-2022-003815

[CR75] Yennurajalingam S, Palmer JL, Zhang T, Poulter V, Bruera E, Currow DC. Association between fatigue and other cancer-related symptoms in patients with advanced cancer. Support Care Cancer. 2013;21(6):1585–91. 10.1007/s00520-012-1694-5. 10.1007/s00520-008-0466-5 18504622

[CR76] Haywood A, Good P, Khan S, Leupp A, Jenkins-Marsh S, Rickett K, et al. Corticosteroids for the management of cancer-related pain in adults. Cochrane Database Syst Rev. 2015;2015(4):CD010756. 10.1002/14651858.CD010756.pub2. 25908299 10.1002/14651858.CD010756.pub2 PMC8127040

[CR77] 77. National Comprehensive Cancer N, American Cancer S. Cancer-related fatigue: practice guidelines for the management of fatigue. Clinical Practice Guidelines in Oncology2005.

[CR78] Monk JP, Phillips G, Waite R, Kuhn J, Schaaf LJ, Otterson GA, et al. Assessment of tumor necrosis factor alpha Blockade as an intervention to improve tolerability of dose-intensive chemotherapy in cancer patients. J Clin Oncol. 2006;24(12):1852–9. 10.1200/JCO.2005.04.2838. 16622259 10.1200/JCO.2005.04.2838

[CR79] Zhang X, Lee WD, Leitner BP, Zhu W, Fosam A, Li Z, et al. Dichloroacetate as a novel pharmaceutical treatment for cancer-related fatigue in melanoma. Am J Physiol Endocrinol Metab. 2023;325(4):E363–75. 10.1152/ajpendo.00105.2023. 37646579 10.1152/ajpendo.00105.2023 PMC10642987

[CR80] Cruciani RA, Zhang JJ, Manola J, Cella D, Ansari B, Fisch MJ. L-carnitine supplementation for the management of fatigue in patients with cancer: an Eastern cooperative oncology group phase III, randomized, double-blind, placebo-controlled trial. J Clin Oncol. 2012;30(31):3864–9. 10.1200/JCO.2011.40.2180. 22987089 10.1200/JCO.2011.40.2180 PMC3478577

[CR81] Ng T Kenny K Yardley J Marfan H Evaluating the role of vitamin D in cancer-related fatigue in breast cancer survivors: A randomized controlled trial Support Care Cancer 2019 27 2 461 8

[CR82] Barton DL, Liu H, Dakhil SR, Linquist B, Sloan JA, Nichols CR, et al. Wisconsin ginseng (Panax quinquefolius) to improve cancer-related fatigue: a randomized, double-blind trial, N07C2. J Natl Cancer Inst. 2013;105(16):1230–8. 10.1093/jnci/djt181. 23853057 10.1093/jnci/djt181 PMC3888141

[CR83] Luo WT, Huang TW. Effects of ginseng on Cancer-Related fatigue: A systematic review and Meta-analysis of randomized controlled trials. Cancer Nurs. 2023;46(2):120–7. 10.1097/NCC.0000000000001068. 35184068 10.1097/NCC.0000000000001068

[CR84] Yennurajalingam S, Tannir NM, Williams JL, Lu Z, Hess KR, Frisbee-Hume S, et al. A Double-Blind, randomized, Placebo-Controlled trial of Panax Ginseng for Cancer-Related fatigue in patients with advanced Cancer. J Natl Compr Canc Netw. 2017;15(9):1111–20. 10.6004/jnccn.2017.0149. 28874596 10.6004/jnccn.2017.0149

[CR85] Yennurajalingam S, Lu Z, Rozman De Moraes A, Tull NN, Kubiak MJ, Geng Y, et al. Meta-Analysis of pharmacological, nutraceutical and phytopharmaceutical interventions for the treatment of Cancer related fatigue. Cancers (Basel). 2022;15(1). 10.3390/cancers15010091. 10.3390/cancers15010091 PMC9817820 36612088

[CR86] Alfano CM, Rowland JH. Recovery issues in cancer survivorship: a new challenge for supportive care. Cancer J. 2006;12(5):432–43. 10.1097/00130404-200609000-00012. 17034679 10.1097/00130404-200609000-00012

[CR87] Groenvold M, Petersen MA, Idler E, Bjorner JB, Fayers PM, Mouridsen HT. Psychological distress and fatigue predicted recurrence and survival in primary breast cancer patients. Breast Cancer Res Treat. 2007;105(2):209–19. 10.1007/s10549-006-9447-x. 17203386 10.1007/s10549-006-9447-x

[CR88] Grach SL, Seltzer J, Chon TY, Ganesh R. Diagnosis and Management of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome. Mayo Clin Proc. 2023;98(10):1544-51. 10.1016/j.mayocp.2023.07.032 10.1016/j.mayocp.2023.07.032 37793728

[CR89] Nacul L, Authier FJ, Scheibenbogen C, Lorusso L, Helland IB, Martin JA, et al. European network on myalgic encephalomyelitis/chronic fatigue syndrome (EUROMENE): expert consensus on the diagnosis, service provision, and care of people with ME/CFS in Europe. Med (Kaunas). 2021;57(5). 10.3390/medicina57050510. 10.3390/medicina57050510 PMC8161074 34069603

[CR90] Barry PW, Kelley K, Tan T, Finlay I. NICE guideline on ME/CFS: robust advice based on a thorough review of the evidence. J Neurol Neurosurg Psychiatry. 2024;95(7):671–4. 10.1136/jnnp-2023-332731. 38418217 10.1136/jnnp-2023-332731

[CR91] Institute of M Beyond myalgic encephalomyelitis/chronic fatigue syndrome: redefining an illness 2015 Washington, DC National Academies

[CR92] Clayton EW. Beyond myalgic encephalomyelitis/chronic fatigue syndrome: an IOM report on redefining an illness. JAMA. 2015;313(11):1101–2. 10.1001/jama.2015.1346. 25668027 10.1001/jama.2015.1346

[CR93] Steiner S, Fehrer A, Hoheisel F, Schoening S, Aschenbrenner A, Babel N, et al. Understanding, diagnosing, and treating myalgic encephalomyelitis/chronic fatigue syndrome - State of the art: report of the 2nd international meeting at the Charite fatigue center. Autoimmun Rev. 2023;22(11):103452. 10.1016/j.autrev.2023.103452. 37742748 10.1016/j.autrev.2023.103452

[CR94] Kingdon C, Lowe A, Shepherd C, Nacul L. What primary care practitioners need to know about the new NICE guideline for myalgic encephalomyelitis/chronic fatigue syndrome in adults. Healthc (Basel). 2022;10(12). 10.3390/healthcare10122438. 10.3390/healthcare10122438 PMC9778354 36553962

[CR95] O’Higgins CM, Brady B, O’Connor B, Walsh D, Reilly RB. The pathophysiology of cancer-related fatigue: current controversies. Support Care Cancer. 2018;26(10):3353–64. 10.1007/s00520-018-4318-7. 29961146 10.1007/s00520-018-4318-7

[CR96] Cortes Rivera M, Mastronardi C, Silva-Aldana CT, Arcos-Burgos M, Lidbury BA. Myalgic encephalomyelitis/chronic fatigue syndrome: A comprehensive review. Diagnostics (Basel). 2019;9(3). 10.3390/diagnostics9030091. 10.3390/diagnostics9030091 PMC6787585 31394725

[CR97] Schmitz KH, Holtzman J, Courneya KS. Controlled physical activity trials in cancer survivors: A systematic review and meta-analysis. Cancer Epidemiol Biomarkers Prev. 2010;14(7):1588–95. 10.1158/1055-9965.EPI-04-0703 16030088

[CR98] Burnham TR, Wilcox A. Effects of exercise on physiological and psychological variables in cancer survivors. Med Sci Sports Exerc. 2002;34(12):1863–7. 10.1097/00005768-200212000-00001. 12471288 10.1097/00005768-200212000-00001

[CR99] Mishra SI Scherer RW Snyder C Geigle P Gotay C Exercise interventions on health-related quality of life for cancer survivors: Meta-analysis of randomized controlled trials Cancer Epidemiol Biomarkers Prev 2012 21 1 3 19

[CR100] Pheby DFH, Friedman KJ, Murovska M, Zalewski P. Turning a corner in ME/CFS research. Med (Kaunas). 2021;57(10). 10.3390/medicina57101012. 10.3390/medicina57101012 PMC8541042 34684049

[CR101] Mitchell SA, Beck SL, Hood LE, Moore K, Tanner ER. Putting evidence into practice: an update of evidence-based interventions for cancer-related fatigue during and following treatment. Clin J Oncol Nurs. 2014;18(6 Suppl):38–58. 25427608 10.1188/14.CJON.S3.38-58

[CR102] Siracusa R, Paola RD, Cuzzocrea S, Impellizzeri D, Fibromyalgia. Pathogenesis, mechanisms, diagnosis and treatment options update. Int J Mol Sci. 2021;22(8). 10.3390/ijms22083891. 10.3390/ijms22083891 PMC8068842 33918736

[CR103] Paice JA, Portenoy R, Lacchetti C, Campbell T, Cheville A, Citron M, et al. Management of chronic pain in survivors of adult cancers: American society of clinical oncology clinical practice guideline. J Clin Oncol. 2016;34(27):3325–45. 10.1200/JCO.2016.68.5206. 27458286 10.1200/JCO.2016.68.5206

[CR104] Porter AB, Liu H, Kohli S, Cerhan JL, Sloan J, McMurray RP, et al. Efficacy of treatment with Armodafinil for Cancer-Related fatigue in patients with High-grade glioma: A phase 3 randomized clinical trial. JAMA Oncol. 2022;8(2):259–67. 10.1001/jamaoncol.2021.5948. 34882169 10.1001/jamaoncol.2021.5948 PMC8662535

[CR105] Blockmans D, Persoons P. Long-term methylphenidate intake in chronic fatigue syndrome. Acta Clin Belg. 2016;71(6):407–14. 10.1080/17843286.2016.1200816. 27351244 10.1080/17843286.2016.1200816

[CR106] Weis J. [Fatigue in chronic physical diseases]. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2024;67(11):1231–8. 10.1007/s00103-024-03951-0. 39284934 10.1007/s00103-024-03951-0 PMC11549205

[CR107] Hill RE, Wakefield CE, Cohn RJ, Fardell JE, Brierley ME, Kothe E, et al. Survivorship care plans in cancer: A Meta-Analysis and systematic review of care plan outcomes. Oncologist. 2020;25(2):e351–72. 10.1634/theoncologist.2019-0184. 32043786 10.1634/theoncologist.2019-0184 PMC7011634

[CR108] Donovan KA, Gonzalez BD, Small BJ, Andrykowski MA, Jacobsen PB, Zachariae R. Depressive symptom trajectories during and after adjuvant treatment for breast cancer. Ann Behav Med. 2017;51(4):469–79. 10.1007/s12160-013-9550-2 PMC4313122 24158626

[CR109] Twomey R, Yeung ST, Wrightson JG, Millet GY, Culos-Reed SN. Post-exertional malaise in people with chronic Cancer-Related fatigue. J Pain Symptom Manag. 2020;60(2):407–16. 10.1016/j.jpainsymman.2020.02.012. 10.1016/j.jpainsymman.2020.02.012 32105793

[CR110] Gagnon DJ, Leclerc AM, Riker RR, Brown CS, May T, Nocella K, et al. Amantadine and modafinil as neurostimulants during Post-stroke care: A systematic review. Neurocrit Care. 2020;33(1):283–97. 10.1007/s12028-020-00977-5. 32394130 10.1007/s12028-020-00977-5

[CR111] Nourbakhsh B, Revirajan N, Morris B, Cordano C, Creasman J, Manguinao M, et al. Safety and efficacy of amantadine, modafinil, and methylphenidate for fatigue in multiple sclerosis: a randomised, placebo-controlled, crossover, double-blind trial. Lancet Neurol. 2021;20(1):38–48. 10.1016/S1474-4422(20)30354-9. 33242419 10.1016/S1474-4422(20)30354-9 PMC7772747

[CR112] Azeem Khan M, Florou V, Swami U. Immunotherapy and fatigue: what we know and what we don’t know. Oncotarget. 2021;12(8):719–20. 10.18632/oncotarget.27946. 33889294 10.18632/oncotarget.27946 PMC8057280

[CR113] Saligan LN Kim HS Wang D Genetic variation and fatigue in breast cancer survivors Support Care Cancer 2015 23 8 2229 37

[CR114] Reyes-Gibby CC, Wang J, Spitz M. Genetic variations in Interleukin 6 and fatigue in patients with breast cancer (Brief report). J Pain Symptom Manag. 2013;46(5):611–8. 10.1016/j.jpainsymman.2012.07.019 PMC3578112 23149083

[CR115] A Study of Cancer Related Fatigue in Patients With Metastatic. Cancer Receiving Anti-PD1 Immunotherapy [database on the Internet]2018. Available from:  https://clinicaltrials.gov/study/NCT03525873 . Accessed.

[CR116] A Combination Therapy to Treat Cancer-Related Fatigue. - NCI R01 [database on the Internet]2018. Available from:  https://clinicaltrials.gov/study/NCT03772834 . Accessed.

[CR117] Alfano CM, Imayama I, Neuhouser ML, Kiecolt-Glaser JK, Smith AW, Meeske K, et al. Fatigue, inflammation, and omega-3 and omega-6 fatty acid intake among breast cancer survivors. J Clin Oncol. 2012;30(12):1280–7. 10.1200/JCO.2011.36.4109. 22412148 10.1200/JCO.2011.36.4109 PMC3341143

[CR118] Groarke JD, Crawford J, Collins SM, Lubaczewski SL, Breen DM, Harrington MA, et al. Phase 2 study of the efficacy and safety of ponsegromab in patients with cancer cachexia: PROACC-1 study design. J Cachexia Sarcopenia Muscle. 2024;15(3):1054–61. 10.1002/jcsm.13435. 38500292 10.1002/jcsm.13435 PMC11154777

[CR119] Peppone LJ, Mustian KM, Morrow GR. The effect of YOCAS©© yoga for musculoskeletal symptoms among breast cancer survivors on hormonal therapy. Breast Cancer Res Treat. 2013;137(2):617–28. 25814054 10.1007/s10549-015-3351-1 PMC4467273

[CR120] Kiecolt-Glaser JK, Bennett JM, Andridge R, Peng J, Shapiro CL, Malarkey WB, et al. Yoga’s impact on inflammation, mood, and fatigue in breast cancer survivors: a randomized controlled trial. J Clin Oncol. 2014;32(10):1040–9. 10.1200/JCO.2013.51.8860. 24470004 10.1200/JCO.2013.51.8860 PMC3965259

[CR121] Abrahams HJG, Gielissen MFM, Schmits IC, Verhagen CAHHVM, Bleijenberg G. The efficacy of Internet-based cognitive behavioral therapy for severely fatigued survivors of breast cancer compared with care as usual: A randomized controlled trial. J Clin Oncol. 2017;35(17):194–204. 28621820 10.1002/cncr.30815

[CR122] Tauber NM, O’Toole MS, Dinkel A, Galica J, Humphris G, Lebel S, et al. Effect of psychological intervention on fear of Cancer recurrence: A systematic review and Meta-Analysis. J Clin Oncol. 2019;37(31):2899–915. 10.1200/JCO.19.00572. 31532725 10.1200/JCO.19.00572 PMC6823887

[CR123] Horneber M, Fischer I, Dimeo F, Ruffer JU, Weis J. Cancer-related fatigue: epidemiology, pathogenesis, diagnosis, and treatment. Dtsch Arztebl Int. 2012;109(9):161–71. 10.3238/arztebl.2012.0161. quiz 72. 22461866 10.3238/arztebl.2012.0161 PMC3314239

[CR124] LeGood NLM, Li X, Ha M, Downer JDR. Prehab? Rehab? Both? Exploring interventions to alleviate disuse-induced muscle atrophy and anabolic resistance in older adults. J Physiol. 2024;602(6):995–6. 10.1113/JP286231. 38412049 10.1113/JP286231

[CR125] Thong MSY, Mols F, van de Poll-Franse LV, Sprangers MAG, van der Rijt CCD, Barsevick AM, et al. Identifying the subtypes of cancer-related fatigue: results from the population-based PROFILES registry. J Cancer Surviv. 2018;12(1):38–46. 10.1007/s11764-017-0641-0. 28889367 10.1007/s11764-017-0641-0

[CR126] Bodenmann S, Landolt HP. Effects of modafinil on the sleep EEG depend on Val158Met genotype of COMT. Sleep. 2010;33(8):1027–35. 10.1093/sleep/33.8.1027. 20815183 10.1093/sleep/33.8.1027 PMC2910532

[CR127] Weymann KB, Wood LJ, Zhu X, Marks DL. A role for orexin in cytotoxic chemotherapy-induced fatigue. Brain Behav Immun. 2014;37:84–94. 10.1016/j.bbi.2013.11.003. 24216337 10.1016/j.bbi.2013.11.003 PMC3951615

[CR128] Chepke C, Jain R, Rosenberg R, Moline M, Yardley J, Pinner K, et al. Improvement in fatigue and sleep measures with the dual orexin receptor antagonist lemborexant in adults with insomnia disorder. Postgrad Med. 2022;134(3):316–25. 10.1080/00325481.2022.2049553. 35254948 10.1080/00325481.2022.2049553

[CR129] Toogood PL, Clauw DJ, Phadke S, Hoffman D. Myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS): where will the drugs come from? Pharmacol Res. 2021;165:105465. 10.1016/j.phrs.2021.105465. 33529750 10.1016/j.phrs.2021.105465

[CR130] de Raaf PJ, Sleijfer S, Lamers CH, Jager A, Gratama JW, van der Rijt CC. Inflammation and fatigue dimensions in advanced cancer patients and cancer survivors: an explorative study. Cancer. 2012;118(23):6005–11. 10.1002/cncr.27613. 22736424 10.1002/cncr.27613

[CR131] Bower JE. The role of neuro-immune interactions in cancer-related fatigue: biobehavioral risk factors and mechanisms. Cancer. 2019;125(3):353–64. 10.1002/cncr.31790. 30602059 10.1002/cncr.31790 PMC6502236

[CR132] Pudrovska T, Anishkin A. Early-life socioeconomic status and physical activity in later life: evidence from structural equation models. J Aging Health. 2013;25(3):383–404. 10.1177/0898264312468601. 23248349 10.1177/0898264312468601 PMC4198340

[CR133] Dimeo FC. Effects of exercise on cancer-related fatigue. Cancer. 2001;92(6 Suppl):1689–93. 10.1002/1097-0142(20010915)92:6+%3C1689::aid-cncr1498%3E3.0.co;2-h. 11598888 10.1002/1097-0142(20010915)92:6+<1689::aid-cncr1498>3.0.co;2-h

[CR134] Bueno de Souza RO, Marcon LF, Arruda ASF, Pontes Junior FL, Melo RC. Effects of mat pilates on physical functional performance of older adults: A Meta-analysis of randomized controlled trials. Am J Phys Med Rehabil. 2018;97(6):414–25.  10.1097/PHM.0000000000000883 . 29283899

[CR135] Campo RA, O’Connor K, Light KC, Nakamura Y, Lipschitz DL, LaStayo PC, et al. Feasibility and acceptability of a Tai Chi Chih randomized controlled trial in senior female cancer survivors. Integr Cancer Ther. 2013;12(6):464–74. 10.1177/1534735413485418. 23620504 10.1177/1534735413485418 PMC3831606

[CR136] van Deuren S, Boonstra A, van Dulmen-den Broeder E, Blijlevens N, Knoop H, Loonen J. Severe fatigue after treatment for childhood cancer. Cochrane Database Syst Rev. 2020;3(3):CD012681. 10.1002/14651858.CD012681.pub2. 32124971 10.1002/14651858.CD012681.pub2 PMC7059965

[CR137] Bower JE. Cancer-related fatigue: links with inflammation in cancer patients and survivors. Brain Behav Immun. 2007;21(7):863–71. 10.1016/j.bbi.2007.03.013. 17543499 10.1016/j.bbi.2007.03.013 PMC3630796

[CR138] Sanft T, Day A, Ansbaugh S, Armenian S, Baker KS, Ballinger T, et al. NCCN Guidelines(R) insights: survivorship, version 1.2023. J Natl Compr Canc Netw. 2023;21(8):792–803. 10.6004/jnccn.2023.0041. 37549906 10.6004/jnccn.2023.0041

[CR139] Hsu T, Ennis M, Hood N, Graham M, Goodwin P. Quality of life in long-term breast cancer survivors. J Clin Oncol. 2011;29(4):415–22. 10.1200/JCO.2012.48.1903 23980087

[CR140] Bower JE, Lamkin DM. Inflammation and cancer-related fatigue: mechanisms, contributing factors, and treatment implications. Brain Behav Immun. 2013;30(S0):S48–57. 10.1016/j.bbi.2012.06.011. 10.1016/j.bbi.2012.06.011 PMC3978020 22776268